Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rui Jie Zeng"'
Publikováno v:
Molecular Oncology, Vol 13, Iss 9, Pp 2010-2030 (2019)
Development of chemoresistance remains a major challenge in treating esophageal squamous cell carcinoma (ESCC) patients despite treatment advances. However, the role of RAC1 in chemoresistance of ESCC and the underlying mechanisms remain largely unkn
Externí odkaz:
https://doaj.org/article/d75580d08c4840bfb6e2b383d57655ed
Autor:
En-Min Li, Si-Meng Wang, Chunwen Zheng, Wan-Xian Chen, Hai-Ying Zou, Wei-Jie Xie, Chi-Bin Cheng, Zheng Li, Rui-Jie Zeng, Li-Yan Xu
Publikováno v:
Bioengineered, Vol 12, Iss 2, Pp 11169-11187 (2021)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
Conventionally, Rho guanine nucleotide exchange factors (GEFs) are known activators of Rho guanosine triphosphatases (GTPases) that promote tumorigenesis. However, the role of Rho GEFs in non-small cell lung cancer (NSCLC) remains largely unknown. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a4100c2a3344eb603d81594b96e3a3
https://doaj.org/article/35e8a165d4994866af3143e4c9754c06
https://doaj.org/article/35e8a165d4994866af3143e4c9754c06
Autor:
Shu Jie Huang, Dan Tian, Si Chao Wang, Rui Jie Zeng, Yue Jiao Dong, Liang Li Hong, Han Sheng Wu, Fang Ping Xu, Dong Kun Zhang, Liang Xie, Hai Yu Zhou, Ji Ming Tang, Xiao Song Ben, Gang Chen, Ri Xin Chen, Yong Tang, Gui Bin Qiao
Publikováno v:
World journal of oncology. 13(4)
The current study attempted to describe the specific patterns of pathological tumor response and locoregional node metastases from surgically resected esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy (NAIC), as well as to explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327365f7e9145e19b2cdf9259687215e
https://pubmed.ncbi.nlm.nih.gov/36128590
https://pubmed.ncbi.nlm.nih.gov/36128590
Publikováno v:
Cancer metastasis reviews. 39(4)
Despite treatment advances, radioresistance and metastasis markedly impair the benefits of radiotherapy to patients with malignancies. Functioning as molecular switches, Rho guanosine triphosphatases (GTPases) have well-recognized roles in regulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1dd86925a7e55d97a63ae6c081e5a2fd
https://pubmed.ncbi.nlm.nih.gov/32772212
https://pubmed.ncbi.nlm.nih.gov/32772212
Background: Conventionally, RHO GEFs are known as activators for RHO GTPases which promote tumorigenesis. However, the role of RHO GEFs in non-small cell lung cancer (NSCLC) remains largely unknown. Methods: A comprehensive bioinformatics analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5351ecf44f204341fd45c0059b5de0c9
https://doi.org/10.21203/rs.3.rs-18164/v1
https://doi.org/10.21203/rs.3.rs-18164/v1
Publikováno v:
Cancer letters. 475
Despite therapeutic advances, resistance to chemotherapy remains a major challenge to patients with malignancies. Rho GTPases are essential for the development and progression of various diseases including cancer, and a vast number of studies have li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1169cdcfa9680a8c84a1ba4a0178c508
https://pubmed.ncbi.nlm.nih.gov/31981606
https://pubmed.ncbi.nlm.nih.gov/31981606